EMVision Awarded $3m Grant For Regional Benefits Study
Filed with ASX · · 3 pages · English
Summary by 6ix AI
EMvision Medical Devices Ltd. has been awarded a significant grant from the Australian Government to conduct a study aimed at improving stroke care in regional areas through telehealth-enabled technology. The grant will support the first clinical study investigating the benefits of the emu point-of-care brain scanner in enhancing stroke diagnosis and treatment workflows. This initiative is expected to generate valuable clinical evidence to drive product adoption and commercialization of EMvision's technology. The project involves collaboration with several partners, including Titan Pre-hospital Innovation and the Australian Stroke Alliance, to ensure effective implementation and outcomes.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
EMvision Medical Devices Ltd. on 6ix
Story so far
Earlier from EMvision Medical Devices
- First Responder Program Advanced & Grant Milestone Achieved
- Key Developments in Pivotal Trial & Innovation Study
- EMVision Awarded $5m Non-Dilutive Government Grant
- Additional Pivotal Trial Site Activations
- Enhanced Algorithm Performance From Continuous Innovation
Later from EMvision Medical Devices
- UCLA Health Activation & Continuous Innovation Study Update
- Appendix 4E & Annual Report to 30 June 2025
- Trading Halt
- Firm Commitments for $12.0M Placement & Launch of SPP
- Pre-Hospital MSU Study Commences with First Responder Device
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices